In 72H, a thousand 3D printed
COVID-19 test tubes.
The CERBALLIANCE, VOLUMIC and LaFERME3D have joined forces to provide an unprecedented response to the problem of out-of-stock COVID-19 screening tests through 3D printing.
CERBALLIANCE(600 testing laboratories in France), commissioned by the ARS (Regional Health Agency) to perform Covid19 screening tests is, as such, equipped in France with several latest-generation screening machines, each of which allows for more than 150 daily analyses.
However, due to the unprecedented magnitude of the threat, laboratories do not have sufficient quantities of test tubes (cups) to keep their automated machines running at full capacity.
Suppliers are unable to meet their customers’ demands, so the official supply chain is broken…so the global cupule supply difficulties are virtually putting these crucial machines out of commission in the merciless battle against the virus!
In an emergency, The Doctor Vincent RAIMONDI, General and Medical Director of CERBALLIANCE Côte d’azur contacted VOLUMIC with a single wish: to design and produce as soon as possible an alternative and validated version of these test tubes!
In less than 72H, relying on the expertise of the FERME3D(particularly on the subjects of waterproofing and mass production), VOLUMIC succeeded in proposing a modeled and then 3D printed version of the test specimens to the team of Dr RAIMONDI. This one launches, in the tread, the technical analyses of validation which confirm that this new material can replace the missing versions with the screening kits.
The companies VOLUMIC and the FERME3D thus prepare to produce in great series this consumable necessary to the realization of the tests of screenings SARS-CoV-2 by RT-PCR.
These screenings will be offered as a priority to healthcare personnel in order to more finely assess/monitor the covid-19 infection status of the medical staff, on the front line in the field.
Rapid screening for Covid-19 is one of the essential links to analyze its expansion and later confirm control of the epidemic thus allowing a safe return to “normal” life.
Thus, in less than 72H, 3D printing provided a vital and concrete response (from prototype to mass production) to an industry known for its demanding nature and whose supply chain was in short supply at a critical time. This unprecedented solution thus allows for the re-use of automated screening machines at the maximum capacity and thus to emergently respond to the exponential need for screening tests on the national territory.
More broadly, having CERBALLIANCE Medical Laboratory and its reagent suppliers validate the reliability of these 3D printed test tubes will trigger a strategic post-crisis reflection on the limitations of conventional manufacturing methodsas well as their critical dependencies on foreign suppliers.
In parallel, and still in close contact with health and scientific authorities as well as the international 3D printing community, VOLUMIC and La FERME3D